CEFDINIR - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cefdinir and what is the scope of freedom to operate?
Cefdinir
is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, Lupin, Sandoz, Teva Pharms, and Abbvie, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.There are twelve drug master file entries for cefdinir. Twenty-eight suppliers are listed for this compound.
Summary for CEFDINIR
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 7 |
NDAs: | 14 |
Drug Master File Entries: | 12 |
Finished Product Suppliers / Packagers: | 28 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 27 |
Patent Applications: | 7,477 |
Drug Prices: | Drug price trends for CEFDINIR |
Drug Sales Revenues: | Drug sales revenues for CEFDINIR |
What excipients (inactive ingredients) are in CEFDINIR? | CEFDINIR excipients list |
DailyMed Link: | CEFDINIR at DailyMed |
Recent Clinical Trials for CEFDINIR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique - Hôpitaux de Paris | Phase 4 |
Northeast Ohio Medical University | Phase 2 |
Mercy Health Ohio | Phase 2 |
Pharmacology for CEFDINIR
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFDINIR
US Patents and Regulatory Information for CEFDINIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anda Repository | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065429-002 | Jul 18, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065337-002 | Apr 6, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065332-001 | May 4, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lupin | CEFDINIR | cefdinir | CAPSULE;ORAL | 065264-001 | May 19, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CEFDINIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | OMNICEF | cefdinir | CAPSULE;ORAL | 050739-001 | Dec 4, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | OMNICEF | cefdinir | FOR SUSPENSION;ORAL | 050749-002 | Jul 29, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | OMNICEF | cefdinir | FOR SUSPENSION;ORAL | 050749-001 | Dec 4, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.